NAPNAP is convening an expert panel for a TeamPeds Town Hall to provide the latest information on pediatric RSV prevention and treatment, including new CDC information about the limited availability of nirsevimab in the United States and interim CDC recommendations to protect infants. Panelists will also respond to audience questions, time permitting.